New Study Investigates COVID Vaccine in Rheumatoid Arthritis, Scleroderma, Myositis, and Sjogren’s Syndrome Patients
September 23, 2021
The University of Pittsburgh Medical Center is recruiting participants for a new study investigating the immune response to the COVID-19 vaccine in those living with autoimmune disease, including rheumatoid arthritis, scleroderma, myositis, and Sjogren’s syndrome.
Autoimmune disease patients were not included in original COVID-19 vaccine clinical trials, and there is “little information regarding the COVID-19 vaccine’s effectiveness and overall safety for patients with autoimmune diseases.” The study will measure antibody levels against SARS-CoV-2, and track whether vaccination leads to disease flares, changes in symptoms, or adverse effects.
To learn more about the study, as well as information on participating, click here.